000			02079 a2200613 4500
005			20250515122125.0
264		0	_c20080916
008			200809s 0 0 eng d
022			_a1528-0020
024	7		_a10.1182/blood-2008-02-138867 _2doi
040			_aNLM _beng _cNLM
100	1		_aChoi, Sung W
245	0	0	_aChange in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival. _h[electronic resource]
260			_bBlood _cAug 2008
300			_a1539-42 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aChild
650	0	4	_aChild, Preschool
650	0	4	_aFemale
650	0	4	_aGraft vs Host Disease _xdiagnosis
650	0	4	_aHematopoietic Stem Cell Transplantation _xadverse effects
650	0	4	_aHumans
650	0	4	_aIncidence
650	0	4	_aInfant
650	0	4	_aInfant, Newborn
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMyeloablative Agonists _xtherapeutic use
650	0	4	_aPredictive Value of Tests
650	0	4	_aPrognosis
650	0	4	_aReceptors, Tumor Necrosis Factor, Type I _xblood
650	0	4	_aSurvival Rate
650	0	4	_aTime Factors
650	0	4	_aTransplantation Conditioning _xadverse effects
650	0	4	_aTransplantation, Homologous
650	0	4	_aTumor Necrosis Factor-alpha _xanalysis
700	1		_aKitko, Carrie L
700	1		_aBraun, Thomas
700	1		_aPaczesny, Sophie
700	1		_aYanik, Gregory
700	1		_aMineishi, Shin
700	1		_aKrijanovski, Oleg
700	1		_aJones, Dawn
700	1		_aWhitfield, Joel
700	1		_aCooke, Kenneth
700	1		_aHutchinson, Raymond J
700	1		_aFerrara, James L M
700	1		_aLevine, John E
773	0		_tBlood _gvol. 112 _gno. 4 _gp. 1539-42
856	4	0	_uhttps://doi.org/10.1182/blood-2008-02-138867 _zAvailable from publisher's website
999			_c17996386 _d17996386